Drug Shortage Report for SPRYCEL
| Report ID | 16413 |
| Drug Identification Number | 02360810 |
| Brand name | SPRYCEL |
| Common or Proper name | dasatinib |
| Company Name | BRISTOL-MYERS SQUIBB CANADA |
| Market Status | MARKETED |
| Active Ingredient(s) | DASATINIB |
| Strength(s) | 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 1 BTL X 30 |
| ATC code | L01XE |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2017-08-04 |
| Actual start date | |
| Estimated end date | 2017-08-04 |
| Actual end date | 2017-08-03 |
| Shortage status | Avoided shortage |
| Updated date | 2017-08-02 |
| Company comments | Product on allocation, other strengths are available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
| Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2017-08-02 | French | Compare |
| v5 | 2017-08-02 | English | Compare |
| v4 | 2017-07-29 | French | Compare |
| v3 | 2017-07-29 | English | Compare |
| v2 | 2017-07-19 | French | Compare |
| v1 | 2017-07-19 | English | Compare |
Showing 1 to 6 of 6